Opus Point Partners Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.4M | Buy |
8,279
+86
| +1% | +$14.6K | 2.54% | 7 |
|
|
2019
Q2 | $1.5M | Buy |
8,193
+119
| +1% | +$21.8K | 2.22% | 5 |
|
|
2019
Q1 | $1.49M | Sell |
8,074
-590
| -7% | -$109K | 2.01% | 7 |
|
|
2018
Q4 | $1.44M | Sell |
8,664
-63
| -0.7% | -$10.4K | 3.16% | 6 |
|
|
2018
Q3 | $1.68M | Sell |
8,727
-604
| -6% | -$116K | 4.02% | 7 |
|
|
2018
Q2 | $1.59M | Buy |
9,331
+107
| +1% | +$18.2K | 3.44% | 6 |
|
|
2018
Q1 | $1.5M | Sell |
9,224
-7,415
| -45% | -$1.21M | 2.95% | 8 |
|
|
2017
Q4 | $2.49M | Sell |
16,639
-1,635
| -9% | -$245K | 2.16% | 11 |
|
|
2017
Q3 | $2.78M | Sell |
18,274
-720
| -4% | -$109K | 2.49% | 9 |
|
|
2017
Q2 | $2.45M | Sell |
18,994
-15,012
| -44% | -$1.93M | 2.24% | 11 |
|
|
2017
Q1 | $3.72M | Buy |
34,006
+649
| +2% | +$71K | 2.76% | 13 |
|
|
2016
Q4 | $2.46M | Buy |
33,357
+1,216
| +4% | +$89.6K | 1.96% | 21 |
|
|
2016
Q3 | $2.8M | Buy |
32,141
+1,893
| +6% | +$165K | 1.57% | 23 |
|
|
2016
Q2 | $2.6M | Sell |
30,248
-10,889
| -26% | -$937K | 2.51% | 15 |
|
|
2016
Q1 | $3.27M | Sell |
41,137
-525
| -1% | -$41.7K | 2.53% | 16 |
|
|
2015
Q4 | $5.24M | Buy |
41,662
+786
| +2% | +$98.9K | 3.46% | 11 |
|
|
2015
Q3 | $4.26M | Buy |
40,876
+5,600
| +16% | +$583K | 2.35% | 17 |
|
|
2015
Q2 | $4.36M | Buy |
35,276
+2,471
| +8% | +$305K | 3.45% | 13 |
|
|
2015
Q1 | $3.87M | Buy |
32,805
+3,709
| +13% | +$438K | 3.24% | 12 |
|
|
2014
Q4 | $3.46M | Buy |
+29,096
| New | +$3.46M | 3.42% | 8 |
|